New imaging study aims to sharpen stroke risk detection
NCT ID NCT07079345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study will use combined PET/MR scans to measure blood flow and glucose metabolism in the brains of 200 people with severe carotid artery narrowing. Participants have already had a mini-stroke or stroke in the past year. The goal is to develop better imaging markers to evaluate disease and guide treatment, not to test a new drug or procedure.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better imaging tools to assess stroke risk and guide treatment decisions for patients with narrowed carotid arteries.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test a new therapy, and the findings may not change current clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Aug 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patient with intracranial artery stenosis due to head and carotid atherosclerosis
- Ages
-
18 to 80 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Angiography diagnosed unilateral anterior circulation head carotid artery stenosis, the diameter of the tube was reduced by \>70%, and the contralateral anterior circulation and bilateral posterior circulation did not exceed the stenosis of \>50% of the diameter reduction; 2. Must have had a transient ischemic attack or ischemic stroke within the area of the diseased vessel within the past 12 months, with the most recent onset being more than 3 weeks; 3. MRI showed no new infarct lesions in the skull; 4. There is no infarct lesion in the previous pontine area; 5. Research participants and informants can complete relevant examinations and follow-ups; 6. Informed consent signed by the study participant or his/her authorized representative; Exclusion Criteria: 1. Poor image quality caused by head movement or other reasons during scanning 2. Presence of other neurological diseases that can cause brain dysfunction (such as depression, brain tumor, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, brain trauma, normal pressure hydrocephalus, etc.) 3. Presence of other systemic diseases that can cause cognitive impairment, such as hepatic insufficiency, renal insufficiency, thyroid dysfunction, severe anemia, folic acid and vitamin B12 deficiency, specific infections (such as syphilis, HIV), alcohol and drug abuse, etc 4. Presence of other known diseases that may cause cognitive impairmentPresence of other known diseases that may cause cognitive impairment 5. Individuals with severe visual or hearing impairment, claustrophobia, or other conditions that prevent cooperation with MRI examination 6. Individuals suffering from diseases that make it impossible to cooperate with cognitive examinations 7. Refusal to sign the informed consent form at baseline
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pet / MR are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Xuanwu Hospitail, Capital Medical University
RECRUITINGBeijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next
- Stroke's hidden heart rhythm clue under investigation
- Hidden blood disorder may explain mysterious strokes in young adults
- After a stroke, does the heart inflame? MRI study probes the link
- Natural capsule tested as Add-On for stroke recovery